Growing Prospects in Emerging Markets

Quality medicines are just the start when looking to grow in developing countries.

Strategy and Strength|May.29, 2018

Patients and doctors in emerging markets want more than just high-quality medicines, says Andrew Lane, executive vice president of Abbott's Established Pharmaceuticals Division (EPD) that sells branded generic drugs solely in fast-growing emerging countries. Andrew's discussion of how companies can do more appears in the publication eyeforpharma.